US SB3233 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 28 2020 - 25% progression, died in committee
Action: 2020-01-28 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 28 2020 - 25% progression, died in committee
Action: 2020-01-28 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Includes certain treatments for hemophilia and other bleeding disorders as high-cost, low-probability ancillary services that may be paid for separately, rather than under the prospective payment (i.e., per diem) system for skilled nursing facilities, under Medicare.
Title
Hemophilia SNF Access Act
Sponsors
| Sen. Robert Menendez [D-NJ] | Sen. Michael Enzi [R-WY] | Sen. Sheldon Whitehouse [D-RI] | Sen. Lisa Murkowski [R-AK] |
| Sen. Shelley Capito [R-WV] | Sen. Jeanne Shaheen [D-NH] | Sen. Kirsten Gillibrand [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-01-28 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB5952 (Same As) 2020-02-25 - Referred to the Subcommittee on Health.
Subjects
Blood and blood diseases
Health
Health care coverage and access
Long-term, rehabilitative, and terminal care
Medicare
Health
Health care coverage and access
Long-term, rehabilitative, and terminal care
Medicare
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3233/all-info |
| Text | https://www.congress.gov/116/bills/s3233/BILLS-116s3233is.pdf |
